QQQ   417.04 (-1.50%)
AAPL   165.06 (-1.19%)
MSFT   399.78 (-1.11%)
META   484.49 (-3.45%)
GOOGL   154.04 (-1.26%)
AMZN   174.75 (-2.49%)
TSLA   149.39 (-0.36%)
NVDA   810.69 (-4.25%)
AMD   149.25 (-3.76%)
NIO   3.83 (-4.25%)
BABA   68.81 (-0.10%)
T   16.37 (+0.24%)
F   12.12 (+0.50%)
MU   107.74 (-3.74%)
GE   149.22 (-2.43%)
CGC   8.13 (+3.83%)
DIS   112.07 (-0.32%)
AMC   3.23 (+10.62%)
PFE   25.78 (+1.54%)
PYPL   62.19 (+0.14%)
XOM   120.10 (+1.33%)
QQQ   417.04 (-1.50%)
AAPL   165.06 (-1.19%)
MSFT   399.78 (-1.11%)
META   484.49 (-3.45%)
GOOGL   154.04 (-1.26%)
AMZN   174.75 (-2.49%)
TSLA   149.39 (-0.36%)
NVDA   810.69 (-4.25%)
AMD   149.25 (-3.76%)
NIO   3.83 (-4.25%)
BABA   68.81 (-0.10%)
T   16.37 (+0.24%)
F   12.12 (+0.50%)
MU   107.74 (-3.74%)
GE   149.22 (-2.43%)
CGC   8.13 (+3.83%)
DIS   112.07 (-0.32%)
AMC   3.23 (+10.62%)
PFE   25.78 (+1.54%)
PYPL   62.19 (+0.14%)
XOM   120.10 (+1.33%)
QQQ   417.04 (-1.50%)
AAPL   165.06 (-1.19%)
MSFT   399.78 (-1.11%)
META   484.49 (-3.45%)
GOOGL   154.04 (-1.26%)
AMZN   174.75 (-2.49%)
TSLA   149.39 (-0.36%)
NVDA   810.69 (-4.25%)
AMD   149.25 (-3.76%)
NIO   3.83 (-4.25%)
BABA   68.81 (-0.10%)
T   16.37 (+0.24%)
F   12.12 (+0.50%)
MU   107.74 (-3.74%)
GE   149.22 (-2.43%)
CGC   8.13 (+3.83%)
DIS   112.07 (-0.32%)
AMC   3.23 (+10.62%)
PFE   25.78 (+1.54%)
PYPL   62.19 (+0.14%)
XOM   120.10 (+1.33%)
QQQ   417.04 (-1.50%)
AAPL   165.06 (-1.19%)
MSFT   399.78 (-1.11%)
META   484.49 (-3.45%)
GOOGL   154.04 (-1.26%)
AMZN   174.75 (-2.49%)
TSLA   149.39 (-0.36%)
NVDA   810.69 (-4.25%)
AMD   149.25 (-3.76%)
NIO   3.83 (-4.25%)
BABA   68.81 (-0.10%)
T   16.37 (+0.24%)
F   12.12 (+0.50%)
MU   107.74 (-3.74%)
GE   149.22 (-2.43%)
CGC   8.13 (+3.83%)
DIS   112.07 (-0.32%)
AMC   3.23 (+10.62%)
PFE   25.78 (+1.54%)
PYPL   62.19 (+0.14%)
XOM   120.10 (+1.33%)
NASDAQ:TRIV

TriVascular Technologies (TRIV) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$5.87
$5.87
50-Day Range
N/A
52-Week Range
$3.98
$11.49
Volume
N/A
Average Volume
18,900 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
TRIV stock logo

About TriVascular Technologies Stock (NASDAQ:TRIV)

Trivascular Technologies, Inc. is a medical device company developing and commercializing technologies to advance minimally invasive treatment of abdominal aortic aneurysms (AAA). The Ovation System, the Company's solution for the treatment of AAA through minimally invasive endovascular aortic repair, or EVAR, is a stent graft platform, providing an alternative to conventional devices. It is designed to specifically address many of the limitations associated with conventional EVAR devices and expand the pool of patients eligible for EVAR. The Company is developing Ovation iX iliac limbs for use with both its Ovation Prime and its Ovation iX and Alto aortic bodies, which are in development. Trivascular is developing Ovation iX aortic bodies for use with both its Ovation Prime and its Ovation iX iliac limbs. The Company is developing an aortic body that together with the iliac limbs makes up the Ovation Alto stent graft.

TRIV Stock News Headlines

The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
World Wide Technology
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
See More Headlines
Receive TRIV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TriVascular Technologies and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:TRIV
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

TRIV Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of TriVascular Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other TriVascular Technologies investors own include Avinger (AVGR), Cardiovascular Systems (CSII), Edwards Lifesciences (EW), NuVasive (NUVA), Endologix (ELGX), ICU Medical (ICUI), Neovasc (NVCN), NxStage Medical (NXTM) and Orthofix Medical (OFIX).

This page (NASDAQ:TRIV) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners